Two classes of biologic agents can accelerate the production of thrombin from partially purified prothrombin. One class is well represented by platelets, the other by a factor obtainable from the plasma globulins. Representatives of both classes are found not only in blood, but also in crude tissue extracts. These two classes of agents are distinct; and they serve different functions in the clotting process.
The two groups of factors as studied in this laboratory"'18 correspond essentially to two old factors; and these factors will be called by their old, familiar names.
When Morawitz" introduced the term "thrombokinase" in 1904, he likened the activation of prothrombin by thrombokinase to the activation of trypsinogen by enterokinase. Pursuing this analogy, he considered the possibility that thrombokinase, like enterokinase, was an enzyme. Moreover, he explicitly recognized that thrombokinase was available in ordinary oxalated plasma.'2 Several further inferences made by Morawitz may or may not have been correct; nevertheless, his brilliant theory cannot be ignored. And it would be hard to deny that a basic property for defining thrombokinase, as conceived by him and as construed by later authors, was its capacity to activate prothrombin.
When Nolf'" introduced the term "thromboplastic substances" in 1908, he considered these substances to be "only adjuvants." He did not propose that they activated prothrombin. In 1911-1912, Howell"' specifically denied that thromboplastin was a direct activator of prothrombin; and he further stated ". . . thrombokinase in the sense used by Morawitz does not exist...." To Howell, thromboplastin was a factor found in preparations of brain cephalin and in platelets; and it functioned by "neutralizing" antithrombin. In 1935, Howell" reiterated these views, but identified the anticoagulant as heparin rather than antithrombin. After thromboplastin has disposed of heparin, "prothrombin is activated to thrombin by calcium without the cooperation of an organic kinase." Thrombokinase and thromboplastin, originally conceived so differently, have sometimes been treated as if they were identical. There have been many reasons. The problem has long been obscured by a haze of unproven assumptions. Perhaps the most misleading of these has been the notion that Received for publication April 3, 1952. one may define a factor simultaneously as "the tissue factor" and as "the prothrombin activator," without first proving that "the tissue factor" is "the prothrombin activator" and without appreciating that at least two different factors can be obtained from crude tissue extracts. If clotting factors were defined primarily in terms of their biochemical function, without reference to the unsettled "tissue factor" problem, thrombokinase could not be confused with Howell's thromboplastin. Because this is the crucial point in need of clarification, it seems desirable to give a detailed report of experiments which reveal several contrasts between the two agents. Prothrormbin (Prothrombin preparation III). The procedure for prothrombin preparation II was followed, up through the precipitation at pH 4.4.18 Then the precipitate (instead of the supernatant as for preparation II) was taken as the prothrombin reagent. It was suspended in 10 ml. distilled water and stored at -17°C. For each day's experiments, the suspension was thawed and a fresh solution was made by diluting a small portion with 9 volumes of buffer.
Kinase. Concentrated thrombokinase, prepared from plasma globulin. '8 Thrombin. The thrombin used was prepared as previously described."8 Crude globulin. Crude plasma globulin, after removal of fibrinogen by heating at 510 C."' Lipoid thromboplastin (Lipid). That fraction of bovine brain, soluble in ether but not in acetone; 10 per cent suspension.'7 A similar preparation, containing both cephalin and lecithin, was used by Eagle.' Ferguson's8 studies showed that clotting activity occurred in several of Folch's subfractions of crude brain cephalin. The possibility that true cephalin is a potent thromboplastin was left open. In a study of lung phosphatides, Cohen and Chargaff' reported that the "lecithin" and "cephalin" fractions showed approximately equal clotting activity. Leathes and Mellanby'3 reported that brain lecithin, but not brain cephalin, potentiated thrombokinase. Such considerations made it desirable to use a rather complete lipoid thromboplastin for the present work.
Trypsin. Dialyzed stock solution of crystallized trypsin. '7 The methods were those described previously.' When prothrombin was activated in the presence of ionic calcium, the relative thrombin values were derived by dividing 3,000 by the observed clotting time. But for activation in the presence of oxalate it was necessary to use a set of empirical curves; for the speed of clotting was not precisely proportional to the amount of thrombin under these conditions. With concentrated thrombokinase, the activation of prothrombin could not be expected to stop upon admixture with oxalated fibrinogen, although it would be retarded by the usual fourfold dilution. The error is slight when the clotting times are short in comparison with the activation times.
The same prothrombin suspension at the same dilution, the same stock of thrombokinase, and the same stock of lipoid thromboplastin were used throughout this work. The activation mixtures contained prothrombin in the dilute state-about one-sixth of the prothrombin concentration of normal plasma. The experiment shown in Figure 1 did not quite eliminate the possibility that the lipid only magnified the effect of the thrombin without actually causing its faster production. In the experiment reported in Table 1 , the lipid did not make the thrombin clot fibrinogen faster, i.e., it did not magnify the effect of the thrombin. Finally, it must be remembered that the amount of thrombin found at any one time is a net value-the total amount of thrombin produced, minus that which has been lost through inactivation or side reactions. It is concluded that the lipid accelerated the net production z 0 II of thrombin, and that this was not a spurious effect attributable merely to a shift in the thrombin assays.
In brief, thrombokinase activated prothrombin in the presence of calcium ions, whereas lipoid thromboplastin did not. Lipoid thromboplastin accelerated production of thrombin when the system contained not only prothrombin, but also calcium ions and thrombokinase. these effects involve an equilibrium with organically bound calcium, and whether tightly bound calcium is important even in the presence of oxalate, are not of immediate concern. It is first important to know which effects obviously require ionic calcium, and which reactions can proceed in the presence of oxalate.
The activation of dialyzed prothrombin by dialyzed thrombokinase proceeded in the presence of 0.01 M oxalate, as shown in Table 2 . Table 3 shows that the concentration of oxalate could be varied over a fourfold range without affecting the rate of activation. In all these tests, the ionic strength was practically constant, within the range 0.170-0.174. However, when the concentration of oxalate was raised to 0.5 M for the experiment shown in Table 4 , the ionic strength became ten times as great, 1.73. Nevertheless, the kinase still activated prothrombin. The second test in Table 4 shows that the high ionic strength did not cause activation of the prothrombin in the absence of kinase. The last test, like the last in Table 2 . reveals that the kinase preparation alone caused very slow coagulation of the fibrinogen, and that this effect was too small to interfere with the tests. It may be noted that 0.5 M oxalate is 25-50 times as much as is ordinarily used to prevent coagulation of whole blood. Figure 2 shows that the early rate of thrombin production, in the presence of 0.01 M oxalate, was directly proportional to the amount of added kinase. This is consistent with the hypothesis that thrombokinase is an enzyme.
Although the reagents were dialyzed, it may still be suspected that 0.01 M oxalate was not really an excess. Therefore, it should be reported that all the oxalated mixtures of Table 2 and Figure 2 remained clear until the end of the experiment. Then a small amount of calcium chloride was added; and all mixtures formed a dense white cloud. Thus, during the experiment, there had been enough oxalate to produce a heavy precipitate, but there had been a lack of ionic calcium.
It may be suspected that the experiments did not allow enough time for the oxalate to bind the calcium. But the time allowed was much longer than that in which oxalate must act on whole blood to prevent the usual 5-10-minute coagulation. Moreover, it has been shown previously'8 that kinase can activate prothrombin continuously for seven hours at room temperature in the presence of excess oxalate.
Why, then, is ionic calcium ordinarily so important for the production of thrombin? Figure 1 shows that when the kinase is dilute and the test reagents partially purified, lipoid thromboplastin greatly accelerates the net rate of thrombin production. As has been reported elsewhere, the accessory thromboplastins so far studied do not exert this effect unless ionic calcium is present. This applies alike to brain lipid, to platelets, and to the accessory thromboplastin found in the globulin fraction of slaughter-house plasma."8
It is likely that accessory thromboplastic action plays a very important r6le in the clotting of whole blood. For this r6le, ionic calcium is needed.
With the present preparations of prothrombin and kinase, the system becomes very sensitive to the addition or omission of calcium ions whenever an accessory thromboplastin is also included. When there is no difference, with or without calcium ions, this is taken as an indication that the system is free of accessory thromboplastins of the type so far studied. Such a conclusion is valid only when the kinase-prothrombin system is known to respond to added thromboplastin plus calcium. Table 5 shows that the addition or omission of calcium chloride made very little difference in the activation of prothrombin by kinase. At the end of a half-hour, the mixtures were adjusted to have the same calcium concentration for the thrombin tests; 30 seconds later, the critical thrombin assays were performed. Within the limits of error, as much thrombin had been produced in 30 minutes without added calcium plus /2 minute with calcium, as had been produced by the control mixture in 30/2 minutes with calcium. The subsequent thrombin assays were performed to show that the mixtures were not completely activated at the time of the critical tests, and hence the critical tests measured the amount of thrombin produced in a definitely known time. Since the rate of thrombin production was not materially influenced by the addition of calcium ions, the presumption is that neither the prothrombin nor kinase contained enough accessory thromboplastin to influence the present tests.
The foregoing experiment was arranged so that no correction was required for the effect of calcium on the thrombin assays. However, previous experiments"8 have shown that even when this consideration was deliberately neglected and no correction made, the difference, with and without calcium, was not great.
In summary, lipoid thromboplastin and ionic calcium were neither absolutely necessary (Fig. 2, Tables 2-5 ) nor together sufficient (Fig. 1) for the activation of prothrombin. Thrombokinase was necessary (Fig. 1) and sufficient (Fig. 2) . Although lipoid thromboplastin did not perform its accessory function without ionic calcium,18 thrombokinase activated prothrombin in the presence of excess oxalate. Tables 6 and 7 , the concentrations of prothrombin and calcium were constant throughout. In Table 6 , the tests had a constant amount of lipid, but varying amounts of kinase. With the four largest amounts of kinase, activation was too fast to permit estimation of the early rate from the five-or ten-minute thrombin assays. For the remaining six tests, covering a 32-fold range of variation in concentration of kinase, the amount of thrombin produced in ten minutes was directly proportional to Figure 3a . The largest amount of kinase plotted in Figure 3a is & as great as the largest amount in Figure 2 . This is, in part, a reflection of the fact that the present preparation of kinase is much more effective in the presence of lipid and calcium.
Quantitative differenices In the experiments of
The last test of Table 6 shows that some thrombin was produced, very slowly, when no kinase was added. This is attributed to the presence of a small amount of kinase in the prothrombin reagent. Similar tests have been used in this laboratory to estimate the varying magnitude of such contamination in different prothrombin preparations. Table 7 shows tests with constant kinase and varying lipid. Great variations in the amount of added lipid made little difference in the amount of thrombin ultimately produced. The rate of thrombin production was determined by, but was not proportional to, the amount of added lipid. This relationship, for the last seven tests, is illustrated graphically in Figure 3a , where it offers a sharp contrast to the "varying kinase" line.
The first three tests in Table 7 show that there was an optimal amount of lipid. Further increase beyond this led to a slightly slower rate of thrombin production. The other end of the scale is particularly interesting, because a sharp acceleration was caused by lipid in a dilution of 1/2560 x 1/11, corresponding to approximately 3.6 micrograms per ml. of activation mixture.
Similar patterns of results were obtained when crystallized pancreatic trypsin was substituted for thrombokinase, as illustrated in Figure 3b . The n.c. = no clot in one hour.
chief difference was that, without added lipid, trypsin had more effect than the kinase preparation. The "varying lipid" curve covered the range of the four smallest amounts used in the experiment of Table 7 . The concentration of trypsin ranged between 0.068 and 0.544 micrograms per ml. of prothrombin activation mixture. In this range, the early rate of thrombin production was directly proportional to the amount of trypsin. Trypsin could also substitute for thrombokinase in that trypsin activates prothrombin in the presence of oxalate. All this is in harmony with the hypothesis that thrombokinase is an enzyme. (Cf. Eagle and Harris.!)
To what extent the "varying lipid" lines are curved because of the mechanism of the lipid effect, and to what extent the curvature might be due to an anticoagulant contaminating the lipid, must be left for future study.
Disregarding theoretical details, the experimental facts can be summarized simply. With the present materials, the early rate of thrombin production was directly proportional to the amount of thrombokinase; it was not directly proportional to the amount of lipoid thromboplastin.
Heat lability Morawitz' pointed out that his thrombokinase was heat-labile. Table 8 shows that thrombokinase derived from slaughter-house plasma is heatlabile. More than 90 per cent of the activity was lost within 15 minutes at 600 C. Nevertheless, some activity could still be detected in the heated kinase, when tested either in 160 SEEDED the presence of oxalate or in WITH KINASE the presence of lipid and cal- brain lipid, platelets lose much of their acceleratory activity in 10 minutes at 700 C." Whether this represents a loss of Howell's thromboplastin or a loss of some additional platelet factor is not yet clear. Although Howell proposed that some heat-labile materials could function like his cephalin preparations, he recognized no heat-labile factor functioning according to the Morawitz concept of thrombokinase. In fact, he denied that such a factor existed.
Thus, heat-lability is not a good criterion for distinguishing thrombokinase from accessory thromboplastins. These factors must be classified according to their respective actions in the clotting system. The Presumptive Two-Stage Test for Prokinase Activator With the purified materials now at hand, and with the present methods, the production of thrombin is never appreciably faster than at the start, as illustrated in Figure 1 . However, when crude globulin is incubated with calcium, detectable thrombin is produced only after a latent period, as illustrated by the "not seeded" curves of Figures 4a and 4b . Then the amount of thrombin increases along an S-shaped curve, which often rises more sharply than the ones illustrated.
It is apparent that the latent period is concerned with a reaction which takes place before thrombin is produced. By separating the components of the crude globulin, and by incubating calcium with the activator components in one tube, and with the prothrombin in another tube, it has been shown that the relevant preliminary reaction occurred in the activator system and not in the prothrombin. The preliminary reaction has been interpreted as the activation of prothrombokinase, and a detailed three-stage analysis has been used to study this reaction.'6 Three-stage analyses demonstrating the effects of thrombokinase1' and lipoid thromboplastin'7 have already been reported. However, the complexity of the procedure has made it advisable to describe the effects in terms of a simpler, though less rigorous, test.
If the latent period in the two-stage test is concerned with the activation of prothrombokinase, then any factor that activates the prokinase should obliterate the latent period, if added in sufficient quantity. As shown in Figure 4a , kinase shortened the latent period at a dilution of 1/110,000 and obliterated the latent period when seeded in larger amount. Comparison with the data in Table 6 reveals that the largest amount of seed kinase could not have exerted much effect by directly activating prothrombin. The seed kinase apparently accelerated the development of more kinase from the crude globulin. This is consistent with the hypothesis that kinase activates prokinase, but other interpretations are possible.
Although the lipid also shortened the latent period, it did not reduce it to less than four minutes, as shown in Figure 4b . The general effect was to increase the slope and raise the height of the curves, with less of a shift to the left. Here, the conclusions are limited by the finding of an optimum at a 1/220 dilution of lipid. As the amount of lipid was increased beyond the optimum, the latent periods became longer.
The results with the two-stage presumptive test do not eliminate the possibility that lipoid thromboplastin is a direct activator of prothrombokinase; but neither do they support that view. Although more complicated interpretations may be entertained, the results are in accord with the view that thrombokinase activates prothrombokinase. The kinetics of prothrombin activation,16 and the effect of varying the amount of kinase are quite consistent with the view that thrombokinase is an enzyme. So is the fact that trypsin can replace thrombokinase, giving results that follow the same pattern.
DISCUSSION
Ferguson and Erickson7 were perhaps the first to describe the complementary effects of trypsin and brain lipid. They further proposed, in 1939, to look for "thromboplastic enzymes" as part of the physiological clotting mechanism. Subsequently, Ferguson, Travis, and Gerheim8' brought forth evidence that a "thromboplastic enzyme" occurred in plasma protein fractions. Recently, Travis and Ferguson's reported that their enzyme preparations potentiated platelet thromboplastic action. They expressed some doubt that the relevant plasma factor was identical with the enzyme, plasmin. Notwithstanding some differences in interpretation, many of the experimental data from their laboratory and from this one have been mutually confirmatory.
In this laboratory also, it has been found that there are two complementary groups of factors which accelerate production of thrombin. Within each group, one material can replace another. Thrombokinase and trypsin appear to be direct activators of prothrombin. Platelets, brain lipid, and a globulin factor (slaughter-house plasma) belong in the complementary group of accessory thromboplastins. It may be noted that both thrombokinase and accessory thromboplastin are independently represented in the globulin fraction of slaughter-house plasma. That is to say, there are at least two "globulin factors" that accelerate production of thrombin. One of them functions as thrombokinase, the other as accessory thromboplastin.
As yet, the hypothesis proposes no mechanism for the action of the accessory factors. Neither does it state that they impinge directly on the corresponding basic reaction. It is only known that they influence the net observable result of the basic reaction.
Calcium is known to influence the activation of crude prothrombokinase.16 This activation follows the course of an autocatalytic reaction. Acceleration of this conversion by a minute amount of kinase is another indication of autocatalysis. The presumptive tests reported here demonstrate that this acceleration can easily be detected with a simple two-stage procedure. SUMMARY 1. Thrombokinase, as obtained from the plasma globulins, has been contrasted with thromboplastin, as found in the brain lipids.
2. Thrombokinase and thromboplastin proved to be distinct factors, with complementary functions. With the two factors together, thrombin was produced much faster than with twice as much of either factor alone.
3. Thrombokinase alone was sufficient for the activation of prothrombin. Neither lipoid thromboplastin nor ionic calcium was absolutely necessary. Thrombokinase activated prothrombin in the presence of excess oxalate.
4. Lipoid thromboplastin and calcium together were not sufficient for the activation of prothrombin. Thrombin was produced very slowly, if at all, unless thrombokinase was included. Lipoid thromboplastin behaved as an accessory factor in that it accelerated production of thrombin, provided that thrombokinase was present.
5. Although ionic calcium had little effect on the activation of prothrombin by thrombokinase, it was very important for the accessory function of lipoid thromboplastin. By these principles, it was shown that both the prothrombin and the thrombokinase preparations were practically devoid of accessory thromboplastin of the type studied.
6. The early rate of thrombin production was directly proportional to the amount of thrombokinase; it was not directly proportional to the amount of lipoid thromboplastin.
7. Trypsin could be substituted for thrombokinase in systems containing prothrombin, thromboplastin, and calcium; and the early rate of thrombin production was directly proportional to the amount of trypsin. Trypsin also could be substituted for thrombokinase in the presence of excess oxalate.
8. Thrombokinase lost most of its activity within 15 minutes at 600 C. Practically all the activity of lipoid thromboplastin remained after 15 minutes at 70°C. But heat-lability is not a good criterion for distinguishing thrombokinase from all accessory thromboplastins. 9 . Thrombokinase, in minute amount, obliterated the latent period in a presumptive two-stage test for prokinase activator. Lipoid thromboplastin did not obliterate the latent period.
The foregoing results are consistent with a theory which, as yet, is limited to factors which had been named by 1912. The theory offers an historical perspective, and the results provide an experimental basis for the consideration of proposed new factors.
